These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
363 related items for PubMed ID: 20096354
1. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies. Cázares-Delgadillo J, Ganem-Rondero A, Quintanar-Guerrero D, López-Castellano AC, Merino V, Kalia YN. Eur J Pharm Sci; 2010 Mar 18; 39(5):387-93. PubMed ID: 20096354 [Abstract] [Full Text] [Related]
2. Comparing metoclopramide electrotransport kinetics in vitro and in vivo. Cázares-Delgadillo J, Aziza IB, Balaguer-Fernández C, Calatayud-Pascual A, Ganem-Rondero A, Quintanar-Guerrero D, Castellano AC, Merino V, Kalia YN. Eur J Pharm Sci; 2010 Oct 09; 41(2):353-9. PubMed ID: 20633643 [Abstract] [Full Text] [Related]
3. Controlled transdermal iontophoresis for poly-pharmacotherapy: Simultaneous delivery of granisetron, metoclopramide and dexamethasone sodium phosphate in vitro and in vivo. Cázares-Delgadillo J, Ganem-Rondero A, Merino V, Kalia YN. Eur J Pharm Sci; 2016 Mar 31; 85():31-8. PubMed ID: 26826281 [Abstract] [Full Text] [Related]
4. Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo. Kalaria DR, Patel P, Merino V, Patravale VB, Kalia YN. Eur J Pharm Biopharm; 2014 Sep 31; 88(1):56-63. PubMed ID: 24525072 [Abstract] [Full Text] [Related]
5. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins. Dubey S, Kalia YN. J Control Release; 2010 Aug 03; 145(3):203-9. PubMed ID: 20423719 [Abstract] [Full Text] [Related]
6. Transdermal iontophoresis of dexamethasone sodium phosphate in vitro and in vivo: effect of experimental parameters and skin type on drug stability and transport kinetics. Cázares-Delgadillo J, Balaguer-Fernández C, Calatayud-Pascual A, Ganem-Rondero A, Quintanar-Guerrero D, López-Castellano AC, Merino V, Kalia YN. Eur J Pharm Biopharm; 2010 Jun 03; 75(2):173-8. PubMed ID: 20332024 [Abstract] [Full Text] [Related]
7. Controlled iontophoretic transport of huperzine A across skin in vitro and in vivo: effect of delivery conditions and comparison of pharmacokinetic models. Kalaria DR, Patel P, Merino V, Patravale VB, Kalia YN. Mol Pharm; 2013 Nov 04; 10(11):4322-9. PubMed ID: 24028565 [Abstract] [Full Text] [Related]
8. Controlled non-invasive transdermal iontophoretic delivery of zolmitriptan hydrochloride in vitro and in vivo. Patel SR, Zhong H, Sharma A, Kalia YN. Eur J Pharm Biopharm; 2009 Jun 04; 72(2):304-9. PubMed ID: 18771728 [Abstract] [Full Text] [Related]
9. In vitro transdermal iontophoretic delivery of penbutolol sulfate. Ita KB, Banga AK. Drug Deliv; 2009 Jan 04; 16(1):11-4. PubMed ID: 19555303 [Abstract] [Full Text] [Related]
10. Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis. Cázares-Delgadillo J, Naik A, Ganem-Rondero A, Quintanar-Guerrero D, Kalia YN. Pharm Res; 2007 Jul 04; 24(7):1360-8. PubMed ID: 17457661 [Abstract] [Full Text] [Related]
11. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate. Kolli CS, Xiao J, Parsons DL, Babu RJ. Drug Dev Ind Pharm; 2012 May 04; 38(5):571-6. PubMed ID: 21980925 [Abstract] [Full Text] [Related]
12. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle. Gratieri T, Pujol-Bello E, Gelfuso GM, de Souza JG, Lopez RF, Kalia YN. Eur J Pharm Biopharm; 2014 Feb 04; 86(2):219-26. PubMed ID: 23791718 [Abstract] [Full Text] [Related]
13. Comparison of the cutaneous iontophoretic delivery of rasagiline and selegiline across porcine and human skin in vitro. Kalaria DR, Patel P, Patravale V, Kalia YN. Int J Pharm; 2012 Nov 15; 438(1-2):202-8. PubMed ID: 22954444 [Abstract] [Full Text] [Related]
14. Transdermal iontophoresis of hydromorphone across hairless rat skin in vitro. Kumar MG, Lin S. Pharm Dev Technol; 2009 Nov 15; 14(1):106-15. PubMed ID: 18825546 [Abstract] [Full Text] [Related]
15. Noninvasive transdermal iontophoretic delivery of biologically active human basic fibroblast growth factor. Dubey S, Perozzo R, Scapozza L, Kalia YN. Mol Pharm; 2011 Aug 01; 8(4):1322-31. PubMed ID: 21696184 [Abstract] [Full Text] [Related]
16. Effect of amino acid sequence on transdermal iontophoretic peptide delivery. Schuetz YB, Naik A, Guy RH, Kalia YN. Eur J Pharm Sci; 2005 Dec 01; 26(5):429-37. PubMed ID: 16143501 [Abstract] [Full Text] [Related]
17. In-vitro and in-vivo transdermal iontophoretic delivery of tramadol, a centrally acting analgesic. Takasuga S, Yamamoto R, Mafune S, Sutoh C, Kominami K, Yoshida Y, Ito M, Kinoshita M. J Pharm Pharmacol; 2011 Nov 01; 63(11):1437-45. PubMed ID: 21988424 [Abstract] [Full Text] [Related]
18. In vitro and in vivo transdermal iontophoretic delivery of naloxone, an opioid antagonist. Yamamoto R, Takasuga S, Yoshida Y, Mafune S, Kominami K, Sutoh C, Kato Y, Yamauchi M, Ito M, Kanamura K, Kinoshita M. Int J Pharm; 2012 Jan 17; 422(1-2):132-8. PubMed ID: 22108639 [Abstract] [Full Text] [Related]
19. In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate. Patel SR, Zhong H, Sharma A, Kalia YN. Eur J Pharm Biopharm; 2007 May 17; 66(2):296-301. PubMed ID: 17182233 [Abstract] [Full Text] [Related]
20. Transdermal iontophoretic delivery of selegiline hydrochloride, in vitro. Kolli CS, Chadha G, Xiao J, Parsons DL, Babu RJ. J Drug Target; 2010 Nov 17; 18(9):657-64. PubMed ID: 20038213 [Abstract] [Full Text] [Related] Page: [Next] [New Search]